Q2 2026 Holdings
Filed 2026-08-14 | 73 holdings | $213.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $3.0K | 18,176 | 0.0% |
| Docgo Inc(DCGO) | COM | 256086109 | $20.2K | 39,062 | 0.0% |
| Lipocine Inc(LPCN) | COM NEW | 53630X203 | $42.8K | 16,712 | 0.0% |
| Quoin Pharmaceuticals LTD(QNRX) | SPONSORED ADS | 74907L409 | $96.8K | 20,000 | 0.0% |
| Elutia Inc(ELUT) | COM | 05479K106 | $161.7K | 165,094 | 0.1% |
| Kyntra BIO Inc(KYNB) | COM NEW | 31572Q881 | $170.4K | 22,566 | 0.1% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $202.8K | 20,655 | 0.1% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $260.7K | 200,543 | 0.1% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $263.0K | 75,147 | 0.1% |
| Kayne Anderson BDC Inc(KBDC) | COM SHS | 48662X105 | $270.6K | 20,000 | 0.1% |
| Grace Therapeutics Inc(GRCE) | COM | 00439U104 | $272.4K | 120,000 | 0.1% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $298.6K | 342,275 | 0.1% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $309.7K | 12,984 | 0.1% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $345.6K | 14,352 | 0.2% |
| Trinity Cap Inc(TRIN) | COM | 896442308 | $357.8K | 20,000 | 0.2% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $364.2K | 20,000 | 0.2% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $419.6K | 42,952 | 0.2% |
| Compass Pathways LTD(CMPS) | SPONSORED ADS | 20451W101 | $424.5K | 30,000 | 0.2% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $464.2K | 152,681 | 0.2% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $491.9K | 47,756 | 0.2% |
| Savara Inc(SVRA) | COM | 805111101 | $492.8K | 80,000 | 0.2% |
| Camp4 Therapeutics Corp(CAMP) | COM | 13463J101 | $524.4K | 120,000 | 0.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $596.8K | 55,000 | 0.3% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $606.7K | 16,487 | 0.3% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $645.1K | 48,505 | 0.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $651.0K | 8,741 | 0.3% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $782.0K | 71,218 | 0.4% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $940.8K | 20,000 | 0.4% |
| Adagene Inc(ADAG) | ADS | 005329107 | $1.0M | 240,000 | 0.5% |
| Harrow Health Inc(HROW) | COM | 415858109 | $1.0M | 24,000 | 0.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $1.0M | 29,847 | 0.5% |
| Immunome Inc(IMNM) | COM | 45257U108 | $1.1M | 50,000 | 0.5% |
| Freeport-Mcmoran CL(FCX) | CL-B | 35671D857 | $1.1M | 18,035 | 0.5% |
| Novo Nordisk A/S(NVO) | ADR | 670100205 | $1.2M | 24,000 | 0.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.3M | 21,032 | 0.6% |
| Structure Therapeutics Inc(GPCR) | SPONS ADR | 86366E106 | $1.3M | 24,000 | 0.6% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $1.3M | 313,616 | 0.6% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $1.4M | 281,937 | 0.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.5M | 6,000 | 0.7% |
| Quidelortho Corp | COM | 74838J101 | $1.6M | 89,377 | 0.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $1.6M | 29,000 | 0.8% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $1.7M | 69,000 | 0.8% |
| EQT Corporation(EQT) | COM | 26884L109 | $1.8M | 34,619 | 0.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.9M | 9,000 | 0.9% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $2.2M | 220,000 | 1.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $2.3M | 17,000 | 1.1% |
| Pacific Biosciences of California Inc(PACB) | COM | 69404D108 | $2.3M | 1,350,000 | 1.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.3M | 50,697 | 1.1% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $2.4M | 93,601 | 1.1% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $2.4M | 4,506 | 1.1% |